Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander G Thompson

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|September 14, 2021
Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosisAlexander G Thompson, Kevin Talbot, Martin R Turner
Clinical Proteomics|January 17, 2026
Tetraspanin-based immunocapture for high-depth proteomic profiling of extracellular vesicles from cerebrospinal fluid for biomarker discoveryElizabeth R Dellar, Iolanda Vendrell, Roman Fischer, et al.
Brain Communications|August 14, 2023
Primary care blood tests show lipid profile changes in pre-symptomatic amyotrophic lateral sclerosisAlexander G Thompson, Rachael Marsden, Kevin Talbot, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 5, 2023
Premorbid brain structure influences risk of amyotrophic lateral sclerosisAlexander G Thompson, Bernd Taschler, Stephen M Smith, et al.
Annals of Clinical and Translational Neurology|August 29, 2025
A Validated Model to Predict Severe Weight Loss in Amyotrophic Lateral SclerosisDavid G Lester, Kevin Talbot, Martin R Turner, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2025
Progression and life expectancy in primary lateral sclerosisDavid G Lester, Alexander G Thompson, Kevin Talbot, et al.
BMJ Neurology Open|September 24, 2024
Personalised penetrance estimation for C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementiaAndrew G L Douglas, Alexander G Thompson, Martin R Turner, et al.
Journal of Neurology|July 29, 2018
Amyotrophic lateral sclerosis: the complex path to precision medicineKevin Talbot, Emily Feneberg, Jakub Scaber, et al.
Practical Neurology|May 16, 2015
Whippits, nitrous oxide and the dangers of legal highsAlexander G Thompson, M Isabel Leite, Michael P Lunn, et al.
Journal of Neurology|September 4, 2024
Apolipoproteins, lipids, lipid-lowering drugs and risk of amyotrophic lateral sclerosis and frontotemporal dementia: a meta-analysis and Mendelian randomisation studyChristos V Chalitsios, Harriet Ley, Jiali Gao, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of Neurology, Neurosurgery, and Psychiatry|September 14, 2021
Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosisAlexander G Thompson, Kevin Talbot, Martin R Turner
Clinical Proteomics|January 17, 2026
Tetraspanin-based immunocapture for high-depth proteomic profiling of extracellular vesicles from cerebrospinal fluid for biomarker discoveryElizabeth R Dellar, Iolanda Vendrell, Roman Fischer, et al.
Brain Communications|August 14, 2023
Primary care blood tests show lipid profile changes in pre-symptomatic amyotrophic lateral sclerosisAlexander G Thompson, Rachael Marsden, Kevin Talbot, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 5, 2023
Premorbid brain structure influences risk of amyotrophic lateral sclerosisAlexander G Thompson, Bernd Taschler, Stephen M Smith, et al.
Annals of Clinical and Translational Neurology|August 29, 2025
A Validated Model to Predict Severe Weight Loss in Amyotrophic Lateral SclerosisDavid G Lester, Kevin Talbot, Martin R Turner, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2025
Progression and life expectancy in primary lateral sclerosisDavid G Lester, Alexander G Thompson, Kevin Talbot, et al.
BMJ Neurology Open|September 24, 2024
Personalised penetrance estimation for C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementiaAndrew G L Douglas, Alexander G Thompson, Martin R Turner, et al.
Journal of Neurology|July 29, 2018
Amyotrophic lateral sclerosis: the complex path to precision medicineKevin Talbot, Emily Feneberg, Jakub Scaber, et al.
Practical Neurology|May 16, 2015
Whippits, nitrous oxide and the dangers of legal highsAlexander G Thompson, M Isabel Leite, Michael P Lunn, et al.
Journal of Neurology|September 4, 2024
Apolipoproteins, lipids, lipid-lowering drugs and risk of amyotrophic lateral sclerosis and frontotemporal dementia: a meta-analysis and Mendelian randomisation studyChristos V Chalitsios, Harriet Ley, Jiali Gao, et al.
Pageof 5